Pharmaron Beijing Co., Ltd. 3759.HK Stock
Pharmaron Beijing Co., Ltd. Price Chart
Pharmaron Beijing Co., Ltd. 3759.HK Financial and Trading Overview
Pharmaron Beijing Co., Ltd. stock price | 9.37 HKD |
Previous Close | 29.9 HKD |
Open | 30.2 HKD |
Bid | 30.3 HKD x N/A |
Ask | 30.35 HKD x N/A |
Day's Range | 29.6 - 30.75 HKD |
52 Week Range | 25.85 - 91.95 HKD |
Volume | 3.56M HKD |
Avg. Volume | 2.31M HKD |
Market Cap | 58.14B HKD |
Beta (5Y Monthly) | 0.692411 |
PE Ratio (TTM) | 20.506756 |
EPS (TTM) | 0.98 HKD |
Forward Dividend & Yield | 0.34 (1.23%) |
Ex-Dividend Date | July 18, 2023 |
1y Target Est | 55.59 HKD |
3759.HK Valuation Measures
Enterprise Value | 39.52B HKD |
Trailing P/E | 20.506756 |
Forward P/E | N/A |
PEG Ratio (5 yr expected) | N/A |
Price/Sales (ttm) | 5.340247 |
Price/Book (mrq) | 3.2928286 |
Enterprise Value/Revenue | 3.63 |
Enterprise Value/EBITDA | 16.816 |
Trading Information
Pharmaron Beijing Co., Ltd. Stock Price History
Beta (5Y Monthly) | 0.692411 |
52-Week Change | -55.17% |
S&P500 52-Week Change | 20.43% |
52 Week High | 91.95 HKD |
52 Week Low | 25.85 HKD |
50-Day Moving Average | 32.33 HKD |
200-Day Moving Average | 41.91 HKD |
3759.HK Share Statistics
Avg. Volume (3 month) | 2.31M HKD |
Avg. Daily Volume (10-Days) | 2.08M HKD |
Shares Outstanding | 201.02M |
Float | 729.71M |
Short Ratio | N/A |
% Held by Insiders | 5.12% |
% Held by Institutions | 68.98% |
Shares Short | N/A |
Short % of Float | N/A |
Short % of Shares Outstanding | N/A |
Dividends & Splits
Trailing Annual Dividend Rate | 0.3 |
Trailing Annual Dividend Yield | 1.00% |
5 Year Average Dividend Yield | N/A |
Payout Ratio | 0.35990003 |
Last Split Factor | 15:10 |
Financial Highlights
Fiscal Year
Fiscal Year Ends | December 31, 2022 |
Most Recent Quarter (mrq) | March 31, 2023 |
Next Fiscal Year End | December 31, 2023 |
Profitability
Profit Margin | 13.53% |
Operating Margin (ttm) | 16.15% |
Gross Margin | 37.14% |
EBITDA Margin | 21.58% |
Management Effectiveness
Return on Assets (ttm) | 5.53% |
Return on Equity (ttm) | 13.55% |
Income Statement
Revenue (ttm) | 10.89B HKD |
Revenue Per Share (ttm) | 9.22 HKD |
Quarterly Revenue Growth (yoy) | 29.50% |
Gross Profit (ttm) | N/A |
EBITDA | 2.35B HKD |
Net Income Avi to Common (ttm) | 1.47B HKD |
Diluted EPS (ttm) | 1.48 |
Quarterly Earnings Growth (yoy) | 39.80% |
Balance Sheet
Total Cash (mrq) | 2.55B HKD |
Total Cash Per Share (mrq) | 2.14 HKD |
Total Debt (mrq) | 6.15B HKD |
Total Debt/Equity (mrq) | 54.59 HKD |
Current Ratio (mrq) | 1.667 |
Book Value Per Share (mrq) | 9.217 |
Cash Flow Statement
Operating Cash Flow (ttm) | 2.26B HKD |
Levered Free Cash Flow (ttm) | -1313709824 HKD |
Profile of Pharmaron Beijing Co., Ltd.
Country | Hong Kong |
State | N/A |
City | Beijing |
Address | 6 Taihe Road |
ZIP | 100176 |
Phone | 86 10 5733 0087 |
Website | https://www.pharmaron.com |
Industry | Biotechnology |
Sector(s) | Healthcare |
Full Time Employees | 19481 |
Pharmaron Beijing Co., Ltd., together with its subsidiaries, provides pharmaceutical research and development services to the life sciences industry in North America, Europe, Mainland China, rest of Asia, and internationally. The company operates through five segments: Laboratory Services; Chemistry, Manufacturing and Controls (CMC) Services; Clinical Development Services; Biologics and Cell and Gene Therapy Services; and Others. It offers laboratory chemistry solutions, including medicinal, synthetic, and analytical and purification chemistry, as well as computer-aided drug design services; bioscience services comprising in vitro and in vivo drug metabolism and pharmacokinetics/absorption, distribution, metabolism, and excretion solutions; and in vitro biology and in vivo pharmacology, safety assessment, and the U.S. laboratory services. The company also provides process development and manufacturing, material science/pre-formulation, formulation development and manufacturing, and analytical development services; and radiolabelled science services and early stage clinical trial services, as well as clinical research and site management services. It also provides business development; and contract research, development, and manufacturing services for pharmaceutical products. The company was incorporated in 2004 and is headquartered in Beijing, the People's Republic of China.
Q&A For Pharmaron Beijing Co., Ltd. Stock
What is a current 3759.HK stock price?
Pharmaron Beijing Co., Ltd. 3759.HK stock price today per share is 9.37 HKD.
How to purchase Pharmaron Beijing Co., Ltd. stock?
You can buy 3759.HK shares on the HKSE exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Pharmaron Beijing Co., Ltd.?
The stock symbol or ticker of Pharmaron Beijing Co., Ltd. is 3759.HK.
Which industry does the Pharmaron Beijing Co., Ltd. company belong to?
The Pharmaron Beijing Co., Ltd. industry is Biotechnology.
How many shares does Pharmaron Beijing Co., Ltd. have in circulation?
The max supply of Pharmaron Beijing Co., Ltd. shares is 3.57B.
What is Pharmaron Beijing Co., Ltd. Price to Earnings Ratio (PE Ratio)?
Pharmaron Beijing Co., Ltd. PE Ratio is 9.56122400 now.
What was Pharmaron Beijing Co., Ltd. earnings per share over the trailing 12 months (TTM)?
Pharmaron Beijing Co., Ltd. EPS is 0.98 HKD over the trailing 12 months.
Which sector does the Pharmaron Beijing Co., Ltd. company belong to?
The Pharmaron Beijing Co., Ltd. sector is Healthcare.
Pharmaron Beijing Co., Ltd. 3759.HK included in indexes
Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
---|
Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
---|---|---|---|---|---|---|---|
{{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
Nasdaq EM Plus Korea Small Cap NQEMKRSCGBP | 1476.35 GBP 1888.16 USD |
<0.01
|
— — | 1476.35 GBP 1888.16 USD | 1476.35 GBP 1888.16 USD | — - | — — |
- {{ link.label }} {{link}}